Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-09

Clinical Trial Update: Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Tenofovir alafenamide versus Entecavir for chronic hepatitis B is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)
  • Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Hepatitis B, Viral Hepatitis | Phase 4 | Status: RECRUITING